08/04/2014 - 12:00 - Sala Marie Curie

Unraveling mechanisms of normal and oncogenic Notch activation

Sessions científiques, PRBB CRG Conferences

Stephen Blacklow

Department of Cancer Biology, Dana-Farber Cancer Institute & Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School. Boston, USA

Blacklow, from the Dana-Farber Cancer Institute and Harvard Medical School, Boston, US, aims to understand the molecular logic of cell-surface receptors, focusing on proteins implicated in human disease. His laboratory currently emphasizes structure-function studies in Notch signalling and maintains an ongoing interest in proteins of the LDL receptor family.

He has been invited by Anna Bigas (IMIM).